Delivery Order SPE2DB20D3303-SPE2DB25FA3SF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a contract ceiling value of $23,977.17. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The order is scheduled for completion by August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) with a ceiling value of $6,717.68. This is a firm fixed-price delivery order with no set-aside designation, completed competitively through open procurement. The order is scheduled for ultimate completion on August 15, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $48,933.00 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order represents a small transaction within AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a ceiling value of $8,588.52. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The order is scheduled for ultimate completion by August 19, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $6,657.98. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is set for completion by September 5, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $51,243.85. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is scheduled for completion by August 21, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Jardiance 10 mg tablets (90-count packaging) valued at $3,836.72. This is a firm fixed-price delivery order with an ultimate completion date of September 9, 2025. The award was made without set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the place of performance and serves as the...
- The Defense Logistics Agency awarded a delivery order valued at $22,046.36 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply requirements. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Jardiance 10 mg tablets (90-count packages) with a contract ceiling value of $7,330.39. This competitively awarded, non-set-aside delivery order carries a firm fixed price structure and is scheduled for completion by May 7, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $2,301.47 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price delivery order represents a non-set-aside award made through open competition and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA3SFDelivery Order
The Defense Logistics Agency awarded a $23,348.57 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Jardiance 10 mg tablets (90-count units). This firm fixed price, competitively awarded delivery order is scheduled for completion by September 16, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competed among eligible vendors in an open procurement process. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs worldwide, including critical medications across multiple therapeutic domains. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability to fulfill federal medical procurement requirements and serves as a critical vendor for Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.3k | 9/15/25 |